These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15834021)

  • 1. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.
    Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
    Kassubek J; Juengling FD; Kioschies T; Henkel K; Karitzky J; Kramer B; Ecker D; Andrich J; Saft C; Kraus P; Aschoff AJ; Ludolph AC; Landwehrmeyer GB
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):213-20. PubMed ID: 14742591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
    Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
    Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset and rate of striatal atrophy in preclinical Huntington disease.
    Aylward EH; Sparks BF; Field KM; Yallapragada V; Shpritz BD; Rosenblatt A; Brandt J; Gourley LM; Liang K; Zhou H; Margolis RL; Ross CA
    Neurology; 2004 Jul; 63(1):66-72. PubMed ID: 15249612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
    Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
    Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of structural neuropathology in pre-clinical Huntington's disease.
    Thieben MJ; Duggins AJ; Good CD; Gomes L; Mahant N; Richards F; McCusker E; Frackowiak RS
    Brain; 2002 Aug; 125(Pt 8):1815-28. PubMed ID: 12135972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.
    Reading SA; Yassa MA; Bakker A; Dziorny AC; Gourley LM; Yallapragada V; Rosenblatt A; Margolis RL; Aylward EH; Brandt J; Mori S; van Zijl P; Bassett SS; Ross CA
    Psychiatry Res; 2005 Oct; 140(1):55-62. PubMed ID: 16199141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
    Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
    Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
    Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
    van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
    J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal change in basal ganglia volume in patients with Huntington's disease.
    Aylward EH; Li Q; Stine OC; Ranen N; Sherr M; Barta PE; Bylsma FW; Pearlson GD; Ross CA
    Neurology; 1997 Feb; 48(2):394-9. PubMed ID: 9040728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study.
    Hobbs NZ; Henley SM; Ridgway GR; Wild EJ; Barker RA; Scahill RI; Barnes J; Fox NC; Tabrizi SJ
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):756-63. PubMed ID: 19955112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain structure in preclinical Huntington's disease.
    Paulsen JS; Magnotta VA; Mikos AE; Paulson HL; Penziner E; Andreasen NC; Nopoulos PC
    Biol Psychiatry; 2006 Jan; 59(1):57-63. PubMed ID: 16112655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.